Search

Your search keyword '"Facciotti F"' showing total 217 results

Search Constraints

Start Over You searched for: Author "Facciotti F" Remove constraint Author: "Facciotti F"
217 results on '"Facciotti F"'

Search Results

1. Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro

2. Lack of Seroconversion Following COVID-19 Vaccination Is an Independent Risk Factor for SARS-CoV-2 Infection in Patients With Inflammatory Bowel Disease: Data from ESCAPE-IBD, an IG-IBD Study

3. Porphyromonas gingivalis fuels colorectal cancer through CHI3L1-mediated iNKT cell-driven immune evasion

4. Distinguishing features of autoimmune gastritis depending on previous H. pylori infection or positivity to anti-parietal cell antibodies: Results from the Autoimmune gastRitis Italian netwOrk Study grOup (ARIOSO)

5. PCGF6 controls murine Tuft cell differentiation via H3K9me2 modification independently of Polycomb repression

7. Evidence for a pathogenic role of extrafollicular, IL-10–producing CCR6⁺B helper T cells in systemic lupus erythematosus

8. Reviving Urban Spaces: Microbial Approaches for Sustainable Regeneration

9. Human Health and Urban Microbiome: the Heritage of a Long Evolutionary Alliance

10. P981 Risankizumab, but not ustekinumab or vedolizumab, downregulates IL-23-induced mucosal pathogenic Th17 cells in patients with Crohn’s disease

12. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: Data of a national study (ESCAPE-IBD)

13. The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease

14. Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study

15. A collaborative robotic solution to partly automate SARS-CoV-2 serological tests in small facilities

16. Automated multimodal fluorescence microscopy for hyperplex spatial-proteomics: Coupling microfluidic-based immunofluorescence to high resolution, high sensitivity, three-dimensional analysis of histological slides

17. Gut microbiota-derived metabolites in host physiology

18. Anti-SARS-CoV-2 immunoglobulin profile in patients with celiac disease living in a high incidence area

19. OC.14.2 LACK OF SEROCONVERSION FOLLOWING COVID-19 VACCINATION, BUT NOT TREATMENT, IS AN INDEPENDENT RISK FACTOR FOR BREAKTHROUGH SARS-COV-2 INFECTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IGIBD STUDY

20. Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice

22. The UniBiome project: microbiome-inspired approaches for a sustainable urban regeneration of Universities

23. Gut microbiota-derived metabolites in host physiology

24. Deciphering the state of immune silence in fatal COVID-19 patients

25. SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 outbreak in Milan

26. Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models

27. Human intestinal and circulating invariant natural killer T cells are cytotoxic against colorectal cancer cells via the perforin–granzyme pathway

28. Seroprevalence of SARS-CoV2 in IBD patients treated with biological therapy

29. Vitamin D supplementation and cancer mortality: Narrative review of observational studies and clinical trials

30. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes

31. Tumor infiltrating Regulatory T cells in sporadic and colitis-associated colorectal cancer: the red little riding hood and the wolf

32. Meta-analysis of diagnostic performance of serological tests for SARS-CoV-2 antibodies up to 25 April 2020 and public health implications

33. License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity

34. The Role of Gut Microbiota Biomodulators on Mucosal Immunity and Intestinal Inflammation

35. Evidence for a pathogenic role of extrafollicular, IL-10-producing CCR6+B helper T cells in systemic lupus erythematosus

36. Persistence of Anti-SARS-CoV-2 Antibodies in Non-Hospitalized COVID-19 Convalescent Health Care Workers

37. Intratumor Microbiome in Neuroendocrine Neoplasms: A New Partner of Tumor Microenvironment? A Pilot Study

38. VITAMIN D SUPPLEMENTATION MAY IMPROVE COVID-19 PROGNOSIS? EVIDENCE FROM A SYSTEMATIC REVIEW AND META-ANALYSIS

39. Tumor infiltrating iNKT cells sustain neutrophil pro-tumorigenic functions influencing disease progression in human colorectal cancer

40. Modulation of intestinal immune cell responses by eubiotic or dysbiotic microbiota in inflammatory bowel diseases

41. Inhibition of the immunoproteasome modulates innate immunity to ameliorate muscle pathology of dysferlin-deficient BlAJ mice

42. Microbiota-targeted therapies in inflammation resolution

43. Lower probability and shorter duration of infections after COVID-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs

44. IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes

45. PC.01.4 REDUCED IMMUNE RESPONSE INDUCED BY TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE - AN IG-IBD STUDY

46. OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

49. Using Robotic Systems to Process and Embed Colonic Murine Samples for Histological Analyses

50. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-gamma coproducing regulatory T cells

Catalog

Books, media, physical & digital resources